Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2002
http://purl.obolibrary.org/obo/NCIT_C2002
|
|---|---|
| Preferred Name | CD22 Immunotoxin |
| Definitions |
An immunotoxin composed of an anti-CD22 monoclonal antibody and a toxin moiety, which targets antigen-positive cells and causes cytotoxic activity. (NCI)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An immunotoxin composed of an anti-CD22 monoclonal antibody and a toxin moiety, which targets antigen-positive cells and causes cytotoxic activity. (NCI) |
|---|---|
| prefLabel | CD22 Immunotoxin
|
| label | CD22 Immunotoxin
|
| PDQ_Closed_Trial_Search_ID | 801521
|
| code | C2002
|
| prefixIRI | NCIT:C2002
|
| in_subset | |
| Preferred_Name | CD22 Immunotoxin
|
| NCI_Drug_Dictionary_ID | 801521
|
| Legacy Concept Name | CD22_Immunotoxin
|
| type | |
| ALT_DEFINITION | A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD22 immunotoxin is made in the laboratory. It binds to CD22, a protein on the surface of normal B cells and B-cell tumors, and kills the cells.
|
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 801521
|
| Semantic_Type | Immunologic Factor
|
| UMLS_CUI | C1511420
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |